Mumtaz score for readmission in cirrhosis
Estimates 30-day readmission risk at discharge for decompensated cirrhosis.
Medium approximate risk band. The original validation cohort stratified patients into low (<20%), medium (20-30%), and high (>30%) predicted probability of 30-day readmission; exact probability requires the published logistic model.
- Risk band
- Medium approximate risk band
When to use
- At discharge in adults with decompensated cirrhosis, to flag patients who may benefit from intensified post-discharge follow-up.
- Not intended for patients on mechanical ventilation, under palliative care, post-liver transplant, or admitted electively.
Formula
Sum of points: age 18-39 (+7), 40-64 (+4), >=65 (0); primary payer Medicare (+4), Medicaid (+5), private (0), self-pay (-3), no charge/other (-1); Elixhauser index >=3 (+2); non-alcoholic etiology (+2); ascites (+5); hepatic encephalopathy (+4); variceal bleeding (-7); hepatocellular carcinoma (+3); paracentesis (+4); hemodialysis (+7); disposition routine (0), transfer (-1), home health (+1), against medical advice (+10). Score range -11 to +49.
Pearls and pitfalls
- Derived and internally validated from the 2013-2014 US Nationwide Readmission Database (>120,000 index admissions for decompensated cirrhosis).
- About 1 in 3 patients with decompensated cirrhosis are readmitted within 30 days, most for a liver-related diagnosis.